428 related articles for article (PubMed ID: 34418279)
1. Tissue factor expression, extracellular vesicles, and thrombosis after infection with the respiratory viruses influenza A virus and coronavirus.
Mackman N; Grover SP; Antoniak S
J Thromb Haemost; 2021 Nov; 19(11):2652-2658. PubMed ID: 34418279
[TBL] [Abstract][Full Text] [Related]
2. Circulating tissue factor-positive extracellular vesicles and their association with thrombosis in different diseases.
Hisada Y; Sachetto ATA; Mackman N
Immunol Rev; 2022 Nov; 312(1):61-75. PubMed ID: 35708588
[TBL] [Abstract][Full Text] [Related]
3. Peripheral blood mononuclear cell tissue factor (F3 gene) transcript levels and circulating extracellular vesicles are elevated in severe coronavirus 2019 (COVID-19) disease.
Girard TJ; Antunes L; Zhang N; Amrute JM; Subramanian R; Eldem I; Remy KE; Mazer M; Erlich EC; Cruchaga C; Steed AL; Randolph GJ; Di Paola J
J Thromb Haemost; 2023 Mar; 21(3):629-638. PubMed ID: 36696180
[TBL] [Abstract][Full Text] [Related]
4. Tissue Factor and COVID-19: An Update.
Sachetto ATA; Mackman N
Curr Drug Targets; 2022 Nov; 23(17):1573-1577. PubMed ID: 36165519
[TBL] [Abstract][Full Text] [Related]
5. Patients With COVID-19 Have Elevated Levels of Circulating Extracellular Vesicle Tissue Factor Activity That Is Associated With Severity and Mortality-Brief Report.
Rosell A; Havervall S; von Meijenfeldt F; Hisada Y; Aguilera K; Grover SP; Lisman T; Mackman N; Thålin C
Arterioscler Thromb Vasc Biol; 2021 Feb; 41(2):878-882. PubMed ID: 33267656
[TBL] [Abstract][Full Text] [Related]
6. Platelet activation by SARS-CoV-2 implicates the release of active tissue factor by infected cells.
Puhm F; Allaeys I; Lacasse E; Dubuc I; Galipeau Y; Zaid Y; Khalki L; Belleannée C; Durocher Y; Brisson AR; Wolberg AS; Langlois MA; Flamand L; Boilard E
Blood Adv; 2022 Jun; 6(12):3593-3605. PubMed ID: 35443030
[TBL] [Abstract][Full Text] [Related]
7. Tissue factor deficiency increases alveolar hemorrhage and death in influenza A virus-infected mice.
Antoniak S; Tatsumi K; Hisada Y; Milner JJ; Neidich SD; Shaver CM; Pawlinski R; Beck MA; Bastarache JA; Mackman N
J Thromb Haemost; 2016 Jun; 14(6):1238-48. PubMed ID: 26947929
[TBL] [Abstract][Full Text] [Related]
8. Lung Epithelial Cell Transcriptional Regulation as a Factor in COVID-19-associated Coagulopathies.
FitzGerald ES; Chen Y; Fitzgerald KA; Jamieson AM
Am J Respir Cell Mol Biol; 2021 Jun; 64(6):687-697. PubMed ID: 33740387
[TBL] [Abstract][Full Text] [Related]
9. Coinfection with SARS-CoV-2 and Influenza A Virus Increases Disease Severity and Impairs Neutralizing Antibody and CD4
Kim EH; Nguyen TQ; Casel MAB; Rollon R; Kim SM; Kim YI; Yu KM; Jang SG; Yang J; Poo H; Jung JU; Choi YK
J Virol; 2022 Mar; 96(6):e0187321. PubMed ID: 35107382
[TBL] [Abstract][Full Text] [Related]
10. SARS-CoV-2 infection induces the activation of tissue factor-mediated coagulation via activation of acid sphingomyelinase.
Wang J; Pendurthi UR; Yi G; Rao LVM
Blood; 2021 Jul; 138(4):344-349. PubMed ID: 34075401
[TBL] [Abstract][Full Text] [Related]
11. Tissue factor upregulation is associated with SARS-CoV-2 in the lungs of COVID-19 patients.
Subrahmanian S; Borczuk A; Salvatore S; Fung KM; Merrill JT; Laurence J; Ahamed J
J Thromb Haemost; 2021 Sep; 19(9):2268-2274. PubMed ID: 34236752
[TBL] [Abstract][Full Text] [Related]
12. SARS-CoV-2 infection mediates differential expression of human endogenous retroviruses and long interspersed nuclear elements.
Marston JL; Greenig M; Singh M; Bendall ML; Duarte RRR; Feschotte C; Iñiguez LP; Nixon DF
JCI Insight; 2021 Dec; 6(24):. PubMed ID: 34731091
[TBL] [Abstract][Full Text] [Related]
13. Platelet activation and platelet-monocyte aggregate formation trigger tissue factor expression in patients with severe COVID-19.
Hottz ED; Azevedo-Quintanilha IG; Palhinha L; Teixeira L; Barreto EA; Pão CRR; Righy C; Franco S; Souza TML; Kurtz P; Bozza FA; Bozza PT
Blood; 2020 Sep; 136(11):1330-1341. PubMed ID: 32678428
[TBL] [Abstract][Full Text] [Related]
14. Global dynamics of IAV/SARS-CoV-2 coinfection model with eclipse phase and antibody immunity.
Elaiw AM; Alsulami RS; Hobiny AD
Math Biosci Eng; 2023 Jan; 20(2):3873-3917. PubMed ID: 36899609
[TBL] [Abstract][Full Text] [Related]
15. SARS-CoV-2 Spike Proteins and Cell-Cell Communication Inhibits TFPI and Induces Thrombogenic Factors in Human Lung Microvascular Endothelial Cells and Neutrophils: Implications for COVID-19 Coagulopathy Pathogenesis.
Bhargavan B; Kanmogne GD
Int J Mol Sci; 2022 Sep; 23(18):. PubMed ID: 36142345
[TBL] [Abstract][Full Text] [Related]
16. Extracellular Vesicle Tissue Factor Activity Assay.
Hisada Y; Mackman N
J Vis Exp; 2023 Dec; (202):. PubMed ID: 38224132
[TBL] [Abstract][Full Text] [Related]
17. Tissue Factor and Extracellular Vesicles: Activation of Coagulation and Impact on Survival in Cancer.
Hisada Y; Mackman N
Cancers (Basel); 2021 Jul; 13(15):. PubMed ID: 34359742
[TBL] [Abstract][Full Text] [Related]
18. GPR183 antagonism reduces macrophage infiltration in influenza and SARS-CoV-2 infection.
Foo CX; Bartlett S; Chew KY; Ngo MD; Bielefeldt-Ohmann H; Arachchige BJ; Matthews B; Reed S; Wang R; Smith C; Sweet MJ; Burr L; Bisht K; Shatunova S; Sinclair JE; Parry R; Yang Y; Lévesque JP; Khromykh A; Rosenkilde MM; Short KR; Ronacher K
Eur Respir J; 2023 Mar; 61(3):. PubMed ID: 36396144
[TBL] [Abstract][Full Text] [Related]
19. Cancer cell-derived tissue factor-positive extracellular vesicles: biomarkers of thrombosis and survival.
Hisada Y; Mackman N
Curr Opin Hematol; 2019 Sep; 26(5):349-356. PubMed ID: 31261175
[TBL] [Abstract][Full Text] [Related]
20. Influenza virus infection increases ACE2 expression and shedding in human small airway epithelial cells.
Schweitzer KS; Crue T; Nall JM; Foster D; Sajuthi S; Correll KA; Nakamura M; Everman JL; Downey GP; Seibold MA; Bridges JP; Serban KA; Chu HW; Petrache I
Eur Respir J; 2021 Jul; 58(1):. PubMed ID: 33419885
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
